Keratosis Follicularis Spinulosa Decalvans: Diagnosis and Therapeutic Evaluation

    January 2015 in “ Journal of clinical case reports
    Khaled Gharib Mohamed Khater
    TLDR KFSD causes scarring hair loss and skin roughness, mainly in males.
    Keratosis Follicularis Spinulosa Decalvans (KFSD) was described as an X-linked genodermatosis that caused scarring alopecia and follicular hyperkeratosis, primarily affecting males while females were carriers with milder symptoms. The document presented a case of two siblings, a 9-year-old boy and a 5-year-old girl, both showing symptoms of KFSD. This condition typically began in infancy or early childhood and fell under the broader category of Keratosis pilaris atrophicans (KPA), which included three rare and distinct clinical entities characterized by scarring types of keratosis pilaris.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 14 results

      community My skin is always dry and flakes like chalk (25)

      in Transgender  6 upvotes 7 months ago
      The user underwent a biopsy two years ago and was diagnosed with keratosis pilaris, leading to hair issues. They tried treatments including Minoxidil, betamethasone, lymecycline, topical Accutane, and dutasteride, as well as diet changes, without improvement in hair thickness or skin dryness.

      community What are these spots on my scalp

      in Treatment  51 upvotes 4 months ago
      A user noticed non-itchy, non-bleeding spots on their scalp while experiencing hair loss. Replies suggest the spots are likely sunspots or liver spots and recommend seeing a dermatologist; hair loss is attributed to male pattern baldness.

      community My Experience and a Discourse on "DUPA"

      in Treatment  9 upvotes 5 months ago
      The user discusses their hair loss experience, exploring various hypotheses including thyroid levels, vitamin D, DHEA, nutritional deficiency, diabetes, seborrheic dermatitis, lack of nutrition to hair follicles, chronic inflammation, female pattern hair loss causes, cortisol, and prolactin levels. They are currently using finasteride, beta-sitosterol, and have tried topical dutasteride and microneedling therapy.

      community The hardest hair protocol ever!

      in Research/Science  9 upvotes 2 years ago
      The user is using RU58841, finasteride, dutasteride, and minoxidil to slow down aggressive hair loss but is still experiencing hair shedding due to high testosterone levels. They plan to use ostarine to lower testosterone and prevent hair loss while maintaining muscle mass, and will continue using the other treatments.

    Similar Research

    6 / 1000+ results
      Histopathologic Evaluation of Alopecias

      research Histopathologic Evaluation of Alopecias

      90 citations, June 2006 in “The American Journal of Dermatopathology”
      The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.
      Primary Cicatricial Alopecia

      research Primary Cicatricial Alopecia

      65 citations, November 2016 in “Journal of The American Academy of Dermatology”
      The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.
      Cicatricial Alopecia: Overview and Treatment Options

      research Cicatricial Alopecia: Overview and Treatment Options

      1 citations, October 2018 in “InTech eBooks”
      The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.
      Cicatricial Alopecia: Overview and Treatment Recommendations

      research Cicatricial Alopecia: Overview and Treatment Recommendations

      23 citations, April 2018 in “Journal der Deutschen Dermatologischen Gesellschaft”
      Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.